PORRINI, RAFFAELE
 Distribuzione geografica
Continente #
NA - Nord America 156
EU - Europa 45
AS - Asia 32
AF - Africa 1
Totale 234
Nazione #
US - Stati Uniti d'America 155
SG - Singapore 18
IT - Italia 15
BE - Belgio 6
CN - Cina 6
IN - India 6
BG - Bulgaria 4
FI - Finlandia 4
SE - Svezia 4
RO - Romania 3
CH - Svizzera 2
IE - Irlanda 2
CA - Canada 1
DE - Germania 1
GB - Regno Unito 1
MY - Malesia 1
NL - Olanda 1
PL - Polonia 1
RU - Federazione Russa 1
TG - Togo 1
VN - Vietnam 1
Totale 234
Città #
Fairfield 31
Seattle 17
Ashburn 14
Singapore 12
Houston 10
Chandler 8
Santa Clara 8
Woodbridge 7
Brussels 6
Rome 6
Wilmington 6
Cambridge 5
Beijing 4
Sofia 4
Plano 3
Princeton 3
Ann Arbor 2
Boardman 2
Boston 2
Dearborn 2
Dublin 2
New York 2
Norwalk 2
Dübendorf 1
Florence 1
Frankfurt am Main 1
Ho Chi Minh City 1
Lausanne 1
Lomé 1
London 1
Los Angeles 1
Millbury 1
Nanjing 1
San Diego 1
Toronto 1
Warsaw 1
Totale 171
Nome #
null 51
null 50
null 45
Concomitant Treatment with Ruxolitinib and Deferasirox in the Management of Iron Overload in Patients with Myelofibrosis: A Multicenter Italian Experience 26
Hemoglobin levels and circulating blasts are two easily evaluable diagnostic parameters highly predictive of leukemic transformation in primary myelofibrosis 23
Anagrelide in Essential Thrombocythemia (ET): Results from 150 patients over 25 years by the ``Ph1-negative Myeloproliferative Neoplasms Latium Group{''} 21
Spleen enlargement is a risk factor for thrombosis in essential thrombocythemia: Evaluation on 1,297 patients 16
Chelation efficacy and erythroid response during deferasirox treatment in patients with myeloproliferative neoplasms in fibrotic phase 15
Prognostic factors for thrombosis-free survival and overall survival in polycythemia vera. A retrospective analysis of 623 PTS With long follow-up 9
Totale 256
Categoria #
all - tutte 993
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 993


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202032 0 0 0 0 0 0 9 7 7 4 3 2
2020/20219 1 2 1 0 0 0 0 0 5 0 0 0
2021/202226 0 0 0 3 6 0 0 3 3 2 0 9
2022/202324 5 3 1 0 3 4 0 2 4 0 1 1
2023/202454 14 6 0 6 8 8 1 2 0 4 2 3
2024/202537 1 2 9 8 6 11 0 0 0 0 0 0
Totale 256